Publications by authors named "J W B Rae"

Article Synopsis
  • Snakebite envenoming poses a significant public health risk in tropical areas, particularly in Malawi, where community understanding of local snakes and first-aid measures is lacking.
  • A survey conducted in Neno District revealed that only 1.3% of participants could accurately identify snakes, less than 5% knew proper first-aid procedures, and 14.3% had adequate knowledge of prevention methods.
  • The findings indicate that both community health workers and members have inadequate knowledge, showing no significant differences between the two groups.
View Article and Find Full Text PDF
Article Synopsis
  • - The RSClinN+ tool was developed to better predict recurrence risk and the benefits of chemotherapy specifically for patients with HR+/HER2-negative, lymph node-positive breast cancer, by incorporating both the Oncotype DX score and other clinical factors like tumor size and age.
  • - Analysis of data from over 5,000 patients revealed that RSClinN+ offered significantly improved prognostic accuracy compared to using the Oncotype DX score alone or clinicopathological models, especially for premenopausal and postmenopausal women.
  • - Validation of RSClinN+ showed that it effectively estimates prognosis and potential chemotherapy benefits, making it a valuable personalized tool for clinicians in managing breast cancer treatment decisions.
View Article and Find Full Text PDF

Inhibition of estrogen receptor alpha (ERα) signaling is an established therapeutic approach for the treatment of ER-positive (ER+) breast cancers, but new therapeutic strategies are urgently needed to overcome clinical resistance. In the present study, we describe the discovery and extensive evaluation of ERD-12310A as an exceptionally potent and orally efficacious PROTAC degrader of ERα. ERD-12310A achieved a DC value of 47 pM and is 10 times more potent than ARV-471.

View Article and Find Full Text PDF
Article Synopsis
  • Current therapies for ERα-positive breast cancer often face challenges due to clinical resistance, creating a need for new treatment options.
  • Researchers have discovered ERD-1233, an oral drug that effectively degrades the ERα protein through innovative PROTAC technology.
  • In preclinical models, ERD-1233 shows significant tumor regression and growth inhibition, suggesting it could be a valuable new therapy for treating ER+ breast cancer.
View Article and Find Full Text PDF
Article Synopsis
  • Specialized nurses play a vital role in implementing telehealth solutions aimed at enhancing quality and safety in home care, which is a key area of current healthcare research.
  • A scoping review analyzed literature from 2013 to 2024, identifying 23 relevant studies that highlighted how specialized nurses utilize telehealth across various fields to ensure patient safety.
  • Key findings included improvements in patient safety through better continuity of care, increased confidence, proactive monitoring, medication safety, patient engagement, and reduced healthcare costs.
View Article and Find Full Text PDF